These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 224162)

  • 1. Infantile hypercalcemia with subcutaneous fat necrosis: endocrine studies.
    Veldhuis JD; Kulin HE; Demers LM; Lambert PW
    J Pediatr; 1979 Sep; 95(3):460-2. PubMed ID: 224162
    [No Abstract]   [Full Text] [Related]  

  • 2. Infantile hypercalcemia with subcutaneous fat necrosis. Report of a case with studies on the pathogenesis of hypercalcemia.
    Yasuda T; Sunami S; Ogura N; Nishioka T; Nakajima H
    Acta Paediatr Scand; 1986 Nov; 75(6):1042-5. PubMed ID: 3564966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis.
    Finne PH; Sanderud J; Aksnes L; Bratlid D; Aarskog D
    J Pediatr; 1988 May; 112(5):792-4. PubMed ID: 3361394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fat necrosis in the newborn infant associated with hypercalcemia and dyslipidemia (description of a case)].
    Marani M; Biasini A; Lotti V; Ciotti F; Miano A; Montaguti A; Ponti R
    Pediatr Med Chir; 1982; 4(5):563-4. PubMed ID: 6927359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia in association with subcutaneous fat necrosis of the newborn: studies of calcium-regulating hormones.
    Cook JS; Stone MS; Hansen JR
    Pediatrics; 1992 Jul; 90(1 Pt 1):93-6. PubMed ID: 1614788
    [No Abstract]   [Full Text] [Related]  

  • 6. An infant with multiple subcutaneous nodules, hypercalcemia, and nephrocalcinosis.
    Tseng MH; Chu SM; Cheng CJ; Lien R; Shih IS; Lin SH
    Pediatr Nephrol; 2013 Dec; 28(12):2283-7. PubMed ID: 23371047
    [No Abstract]   [Full Text] [Related]  

  • 7. Infantile hypercalcemia: a defect in the esterification of 1,25-dihydroxyvitamin D?
    Weisman Y; Harell A; Edelstein S
    Med Hypotheses; 1979 Mar; 5(3):379-82. PubMed ID: 459990
    [No Abstract]   [Full Text] [Related]  

  • 8. Normocalcemic pseudohypoparathyroidism. Association with normal vitamin D3 metabolism.
    Drezner MK; Haussler MR
    Am J Med; 1979 Mar; 66(3):503-8. PubMed ID: 219689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Humoral mechanisms in neoplastic hypercalcemia].
    Gennari C; Montagnani M; Nami R; Francini G
    Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous fat necrosis in a newborn associated with asymptomatic and uncomplicated hypercalcemia.
    Ladoyanni E; Moss C; Brown RM; Ogboli M
    Pediatr Dermatol; 2009; 26(2):217-9. PubMed ID: 19419478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
    Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
    J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous nodules and hypercalcemia in an infant. Subcutaneous fat necrosis of the newborn.
    Liu FT; Dobry MM; Shames BS; Goltz RW
    Arch Dermatol; 1993 Jul; 129(7):898-901-2. PubMed ID: 8323314
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma.
    Spiegel A; Greene M; Magrath I; Balow J; Marx S; Aurbach GD
    Am J Med; 1978 Apr; 64(4):691-5. PubMed ID: 206138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for 1,25(OH)2-vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells.
    Partridge NC; Frampton RJ; Eisman JA; Michelangeli VP; Elms E; Bradley TR; Martin TJ
    FEBS Lett; 1980 Jun; 115(1):139-42. PubMed ID: 6248375
    [No Abstract]   [Full Text] [Related]  

  • 15. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
    Godsall JW; Burtis WJ; Insogna KL; Broadus AE; Stewart AF
    Recent Prog Horm Res; 1986; 42():705-50. PubMed ID: 3016837
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature.
    Hicks MJ; Levy ML; Alexander J; Flaitz CM
    Pediatr Dermatol; 1993 Sep; 10(3):271-6. PubMed ID: 8415307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
    Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
    N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn.
    Hung SH; Tsai WY; Tsao PN; Chou HC; Hsieh WS
    J Formos Med Assoc; 2003 Nov; 102(11):801-4. PubMed ID: 14724728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors.
    Seyberth HW; Segre GV; Hamet P; Sweetman BJ; Potts JT; Oates JA
    Trans Assoc Am Physicians; 1976; 89():92-104. PubMed ID: 190750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.